首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >Isolation and Biological Evaluation of Prenylated Flavonoids from Maclura pomifera
【2h】

Isolation and Biological Evaluation of Prenylated Flavonoids from Maclura pomifera

机译:绒毛Macnura烯丙基黄酮类化合物的分离及生物学评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Phytochemical analysis of the ethanolic extract of Maclura pomifera fruits yielded four new compounds (>I–>IV) along with eleven known compounds (>V–>XV). The crude extract exhibited significant activity towards cannabinoid receptors (CB1: 103.4% displacement; CB2: 68.8% displacement) and possibly allosteric interaction with δ and μ opioid receptors (−49.7 and −53.8% displacement, resp.). Compound> I was found to be possibly allosteric for κ and μ opioid receptors (−88.4 and −27.2% displacement, resp.) and showed moderate activity (60.5% displacement) towards CB1 receptor. Compound> II exhibited moderate activity towards cannabinoid receptors CB1 and CB2 (47.9 and 42.3% displacement, resp.). The known compounds (>V–>VIII) exhibited prominent activity towards cannabinoid receptors: pomiferin (>V) (IC50 of 2.110 and 1.318 μM for CB1 and CB2, resp.), auriculasin (>VI) (IC50 of 8.923 μM for CB1), warangalone (>VII) (IC50 of 1.670 and 4.438 μM for CB1 and CB2, resp.), and osajin (>VIII) (IC50 of 3.859 and 7.646 μM for CB1 and CB2, resp.). The isolated compounds were also tested for inhibition of human monoamine oxidase-A and monoamine oxidase-B enzymes activities, where all the tested compounds showed fewer inhibitory effects on MAO-A compared to MAO-B activities: auriculasin (>VI) (IC50 of 1.91 and 45.98 μM for MAO-B and MAO-A, resp.).
机译:对Maclura pomifera果实的乙醇提取物进行植物化学分析后,产生了四种新化合物(> I – > IV )以及十一种已知化合物(> V – ) > XV )。粗提物对大麻素受体具有显着活性(CB1:位移为103.4%; CB2:位移为68.8%),并可能与δ和μ阿片受体发生变构相互作用(位移分别为-49.7和-53.8%)。发现化合物> I 对κ和μ类阿片受体可能具有别构性(分别为−88.4和−27.2%位移),并且对CB1受体显示中等活性(位移为60.5%)。化合物> II 对大麻素受体CB1和CB2表现出中等活性(分别为47.9%和42.3%位移)。已知化合物(> V – > VIII )对大麻素受体表现出突出的活性:pomiferin(> V )(CB1和C50的IC50为2.110和1.318μM。分别为CB2),金耳菌素(> VI )(CB1的IC50为8.923μM),warangalone(> VII )(CB1和CB2的IC50为1.670和4.438μM )和osajin(> VIII )(对于CB1和CB2,IC50为3.859和7.646μM,分别为)。还测试了分离出的化合物对人单胺氧化酶-A和单胺氧化酶-B酶的抑制作用,与​​MAO-B活性相比,所有测试化合物对MAO-A的抑制作用均较小:auriculasin(> VI )(对于MAO-B和MAO-A,IC50为1.91和45.98.μM)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号